应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
HRMY Harmony Biosciences Holdings, Inc.
盘后交易 11-22 17:53:55 EST
34.07
+0.84
+2.53%
盘后
35.48
+1.41
+4.14%
17:40 EST
最高
34.17
最低
32.90
成交量
51.79万
今开
33.17
昨收
33.23
日振幅
3.82%
总市值
19.43亿
流通市值
15.01亿
总股本
5,703万
成交额
1,751万
换手率
1.18%
流通股本
4,406万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Harmony Biosciences Holdings, Inc.2024财年第三财季实现净利润46.09百万美元，同比增加19.84%
市场透视 · 11-03
Harmony Biosciences Holdings, Inc.2024财年第三财季实现净利润46.09百万美元，同比增加19.84%
Harmony Biosciences Holdings, Inc.盘中异动 早盘股价大涨5.04%报33.75美元
市场透视 · 11-01
Harmony Biosciences Holdings, Inc.盘中异动 早盘股价大涨5.04%报33.75美元
BUZZ--美国股票走势-雅诗兰黛、DoorDash、Peloton Interactive
Reuters · 11-01
BUZZ--美国股票走势-雅诗兰黛、DoorDash、Peloton Interactive
异动解读 | 和谐生物二次发行导致股价盘前大跌5.3%
异动解读 · 10-31
异动解读 | 和谐生物二次发行导致股价盘前大跌5.3%
BUZZ-和谐生物在二次发行定价后下跌
Reuters · 10-31
BUZZ-和谐生物在二次发行定价后下跌
BUZZ-二次发行定价后的和谐生物科学公司
路透中文 · 10-31
BUZZ-二次发行定价后的和谐生物科学公司
异动解读 | Harmony Biosciences发行新股导致股价大跌
异动解读 · 10-31
异动解读 | Harmony Biosciences发行新股导致股价大跌
BUZZ-Harmony Biosciences 在公布二次发行后下滑
Reuters · 10-31
BUZZ-Harmony Biosciences 在公布二次发行后下滑
Harmony Biosciences Holdings, Inc.股价重挫11.54% 市值跌2.42亿美元
市场透视 · 10-30
Harmony Biosciences Holdings, Inc.股价重挫11.54% 市值跌2.42亿美元
异动解读 | 和谐生物科学公司第三季度财报超预期 股价大涨16%
异动解读 · 10-30
异动解读 | 和谐生物科学公司第三季度财报超预期 股价大涨16%
和谐生物科学控股公司公布截至 9 月 30 日的季度业绩 - 收益摘要
Reuters · 10-29
和谐生物科学控股公司公布截至 9 月 30 日的季度业绩 - 收益摘要
异动解读 | 和谐生物第三季度超预期财报 盘中股价大涨6%
异动解读 · 10-29
异动解读 | 和谐生物第三季度超预期财报 盘中股价大涨6%
异动解读 | 和谐生物第三季度财报向好 股价盘前大涨6%
异动解读 · 10-29
异动解读 | 和谐生物第三季度财报向好 股价盘前大涨6%
BUZZ-第三季度收入超过预期，和谐公司股价上涨
Reuters · 10-29
BUZZ-第三季度收入超过预期，和谐公司股价上涨
Harmony Biosciences Holdings, Inc.盘中异动 早盘急速下挫5.22%
市场透视 · 10-02
Harmony Biosciences Holdings, Inc.盘中异动 早盘急速下挫5.22%
Harmony Biosciences Holdings, Inc.盘中异动 快速拉升5.01%
市场透视 · 09-26
Harmony Biosciences Holdings, Inc.盘中异动 快速拉升5.01%
Harmony Biosciences Holdings, Inc.2024财年第二财季实现净利润11.59百万美元，同比减少66.21%
自选股智能写手 · 08-15
Harmony Biosciences Holdings, Inc.2024财年第二财季实现净利润11.59百万美元，同比减少66.21%
Harmony Biosciences Holdings, Inc.盘中异动 临近收盘股价大涨5.00%
自选股智能写手 · 08-14
Harmony Biosciences Holdings, Inc.盘中异动 临近收盘股价大涨5.00%
BUZZ-Harmony Biosciences 第二季度业绩超预期后上涨
Reuters · 08-07
BUZZ-Harmony Biosciences 第二季度业绩超预期后上涨
异动解读 | 和谐生物科学控股公司季绩超预期 股价大涨7.69%
异动解读 · 08-06
异动解读 | 和谐生物科学控股公司季绩超预期 股价大涨7.69%
暂无数据
公司概况
公司名称：
Harmony Biosciences Holdings, Inc.
所属市场：
NASDAQ
上市日期：
--
主营业务：
Harmony Biosciences Holdings, Inc.于2017年7月25日成立，是一家商业阶段的制药公司，致力于为患有罕见的神经系统疾病且未满足医疗需求的患者开发和商业化创新疗法。该公司的产品WAKIX（pitolisant）是具有新颖作用机制或MOA的一流分子，专门设计用于通过与H3受体结合来增强大脑中的组胺信号传导。
发行价格：
--
{"stockData":{"symbol":"HRMY","market":"US","secType":"STK","nameCN":"Harmony Biosciences Holdings, Inc.","latestPrice":34.07,"timestamp":1732309200000,"preClose":33.23,"halted":0,"volume":517893,"hourTrading":{"tag":"盘后","latestPrice":35.48,"preClose":34.07,"latestTime":"17:40 EST","volume":31322,"amount":1067080.182506,"timestamp":1732315209301},"delay":0,"floatShares":44057828,"shares":57031297,"eps":2.105627,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.84,"latestTime":"11-22 17:53:55 EST","open":33.17,"high":34.17,"low":32.9,"amount":17513616.065115,"amplitude":0.038218,"askPrice":36.5,"askSize":20,"bidPrice":31.66,"bidSize":5,"shortable":3,"etf":0,"ttmEps":2.105627,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732323600000},"adr":0,"listingDate":1597809600000,"adjPreClose":33.23,"preHourTrading":{"tag":"盘前","latestPrice":33.23,"preClose":33.23,"latestTime":"09:12 EST","volume":1,"amount":33.23,"timestamp":1732284735399},"postHourTrading":{"tag":"盘后","latestPrice":35.48,"preClose":34.07,"latestTime":"17:40 EST","volume":31322,"amount":1067080.182506,"timestamp":1732315209301},"volumeRatio":1.253617,"impliedVol":0.5645,"impliedVolPercentile":0.0952},"requestUrl":"/m/hq/s/HRMY/tweets","defaultTab":"tweets","newsList":[{"id":"2480758968","title":"Harmony Biosciences Holdings, Inc.2024财年第三财季实现净利润46.09百万美元，同比增加19.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480758968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480758968?lang=zh_cn&edition=full","pubTime":"2024-11-03 00:01","pubTimestamp":1730563278,"startTime":"0","endTime":"0","summary":"11月3日，Harmony Biosciences Holdings, Inc.公布财报，公告显示公司2024财年第三财季净利润为46.09百万美元，同比增加19.84%；其中营业收入为1.86亿美元，同比增加16.25%，每股基本收益为0.81美元。机构评级：截至2024年11月3日，当前有9家机构对Harmony Biosciences Holdings, Inc.目标价做出预测，其中目标均价为47.11美元，其中最低目标价为28.00美元，最高目标价为59.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241103000206ab98f56c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241103000206ab98f56c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HRMY"],"gpt_icon":0},{"id":"2480331268","title":"Harmony Biosciences Holdings, Inc.盘中异动 早盘股价大涨5.04%报33.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480331268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480331268?lang=zh_cn&edition=full","pubTime":"2024-11-01 23:25","pubTimestamp":1730474737,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日23时25分，Harmony Biosciences Holdings, Inc.股票出现异动，股价大幅上涨5.04%。截至发稿，该股报33.75美元/股，成交量208.738万股，换手率3.66%，振幅6.75%。Harmony Biosciences Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Harmony Biosciences Holdings, Inc.公司简介：Harmony Biosciences Holdings Inc是一家商业阶段的制药公司，致力于为患有罕见的神经系统疾病且未满足医疗需求的患者开发和商业化创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110123253898e400b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110123253898e400b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","HRMY"],"gpt_icon":0},{"id":"2480205153","title":"BUZZ--美国股票走势-雅诗兰黛、DoorDash、Peloton Interactive","url":"https://stock-news.laohu8.com/highlight/detail?id=2480205153","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480205153?lang=zh_cn&edition=full","pubTime":"2024-11-01 01:26","pubTimestamp":1730395596,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串：[STXBZ］ * The Day Ahead 新闻通讯： * The Morning News Call时事通讯： 10月31日 - 华尔街周四下跌，原因是微软和 Meta Platforms 就人工智能成本飙升发出的警告打击了市场对大型股的热情，而这些大型股今年以来一直领涨市场。美东时间13:03，道琼斯工业平均指数 报41950.41点，下跌0.4%。标普500指数 下跌1.34%，报5735.53点；纳斯达克综合指数 下跌2.31%，报18177.527点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COP","DASH","REGN","QLD","SQQQ","XEL","IP",".IXIC","DXD","HRMY","MO","NXT","BMY",".DJI","MSFT","AVGO","TFX","CWH","SDOW",".SPX","IDXX","DOG","SO","EBAY","MNQmain","NCLH","QID","CVX","KIM","LNG","PTON","APLD","CMCSA","CI","IQV","TQQQ","MRK","BALL","EL","DDM","WEN","DJX","PBF","META","ENVX","ETSY","RELY"],"gpt_icon":1},{"id":"1183600802","title":"异动解读 | 和谐生物二次发行导致股价盘前大跌5.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183600802","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183600802?lang=zh_cn&edition=full","pubTime":"2024-10-31 19:24","pubTimestamp":1730373864,"startTime":"0","endTime":"0","summary":"2024年10月31日盘前,和谐生物科学股价大跌5.3%,报收32美元。这一下跌与公司前一天晚间宣布的二次发行定价密切相关。据报道,和谐生物周三晚间宣布进行二次发行,共计800万股,由Marshman Fund Trust和Valor Equity Partners以每股31美元的价格出售。在此次二次发行中,Marshman基金信托减持了400万股,使其持股比例降至约11.7%;而总部位于芝加哥的私募股权公司Valor减持后持股比例为约12.7%。增发新股将导致公司现有股本大幅扩张,从而引发股价下跌。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 和谐生物二次发行导致股价盘前大跌5.3%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HRMY"],"gpt_icon":0},{"id":"2479702606","title":"BUZZ-和谐生物在二次发行定价后下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2479702606","media":"Reuters","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479702606?lang=zh_cn&edition=full","pubTime":"2024-10-31 19:21","pubTimestamp":1730373708,"startTime":"0","endTime":"0","summary":" 10月31日 - ** Harmony Biosciences 二次发行定价后，股价盘前下跌5.3%，至32美元。** 以罕见神经疾病为重点的制药公司周三晚些时候宣布， 800万股，由Marshman Fund Trust和Valor Equity Partners以31美元的价格出售。** HRMY 股价周三暴跌 18.5%，收于 33.80 美元，创去年 10 月以来最大单日跌幅。 ** 周二，HRMY 股价上涨 16.1%，报收于 41.49 美元，该公司公布的 第三季度营收和 GAAP 每股收益均高于共识水平。** 截至本周三，股价累计上涨约 5%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211326755.USD","BK4585","BK4533","IE00BJTD4V19.USD","LU0149725797.USD","LU0976567544.SGD","LU1244550221.USD","BK4007","LU0203345920.USD","LU0238689110.USD","BK4566","LU0320765489.SGD","LU0203347892.USD","LU0170899867.USD","LU0256863811.USD","IE0034235295.USD","LU0971096721.USD","IE00BJTD4N35.SGD","LU1084165304.USD","LU1119994496.HKD","IE00BLSP4239.USD","IE00BYXW3230.USD","LU0215105999.USD","LU0417517546.SGD","LU1064131342.USD","IE00BKDWB100.SGD","BK4504","LU0323591593.USD","LU0211326839.USD","LU","IE00BDRTCR15.USD","IE00BZ1G4Q59.USD","LU0208291251.USD","BK4588","LU0310799852.SGD","LU0320765646.SGD","IE00BBT3K403.USD","LU0683600562.USD","LU0787776722.HKD","LU0267386448.USD","BK4550","IE00BWXC8680.SGD","HRMY","IE00B775SV38.USD","IE00B3S45H60.SGD","IE00B1XK9C88.USD","IE00BKVL7J92.USD","LU0211328371.USD","LU0211327993.USD","BK4534"],"gpt_icon":1},{"id":"2479855750","title":"BUZZ-二次发行定价后的和谐生物科学公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2479855750","media":"路透中文","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479855750?lang=zh_cn&edition=full","pubTime":"2024-10-31 19:20","pubTimestamp":1730373620,"startTime":"0","endTime":"0","summary":"10月31日 - ** Harmony Biosciences HRMY.O二次发行定价后，股价盘前下跌5.3%，至32美元。** 截至本周三，股价累计上涨约 5%。2023 年 10 月 31 日股价收于 23.54 美元(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241031:nL4T3M71FE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765489.SGD","BK4534","LU0417517546.SGD","LU0320765646.SGD","LU0070302665.USD","BK4588","LU1119994496.HKD","LU0496365809.HKD","BK4504","IE00BBT3K403.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU","IE00BFXG1179.USD","LU1162221912.USD","IE00B1XK9C88.USD","LU1244550221.USD","BK4007","LU0106831901.USD","IE00B775SV38.USD","LU0234572021.USD","HRMY","LU0267386448.USD","LU0323591593.USD","LU1064131342.USD","BK4533","IE0034235295.USD","IE00B1BXHZ80.USD","BK4516","LU0211326839.USD","LU0683600562.USD","LU0882574139.USD","LU0208291251.USD","LU0971096721.USD","LU0256863811.USD","IE00BHPRN162.USD","IE0034235188.USD","BK4207","IE00BKDWB100.SGD","IE00BLSP4239.USD","IE00BJTD4V19.USD","LU0976567544.SGD","LU0149725797.USD","IE000M9KFDE8.USD","LU0211331839.USD","IE00BJTD4N35.SGD","IE00B3S45H60.SGD","IE00BYXW3230.USD","BK4566","BK4550"],"gpt_icon":0},{"id":"1177744381","title":"异动解读 | Harmony Biosciences发行新股导致股价大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1177744381","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177744381?lang=zh_cn&edition=full","pubTime":"2024-10-31 00:30","pubTimestamp":1730305826,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings Inc.今日盘中股价大跌18%,引发市场广泛关注。据相关消息报道,该公司近期宣布发行800万股新股,这一举措可能是导致其股价大幅波动的原因。Harmony Biosciences是一家专注于罕见神经系统疾病治疗领域的制药公司。分析人士指出,发行新股一旦供给量增加,往往会对股价形成短期压力,尤其是规模较大的发行。此次发行800万股相较于现有股本规模较大,所以引发投资者抛售。不过一旦新股发行完毕、市场供需关系重新平衡,该股价格变动将趋于理性化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HRMY"],"gpt_icon":0},{"id":"2479739807","title":"BUZZ-Harmony Biosciences 在公布二次发行后下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2479739807","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479739807?lang=zh_cn&edition=full","pubTime":"2024-10-31 00:27","pubTimestamp":1730305626,"startTime":"0","endTime":"0","summary":" 10月30日 - ** Harmony Biosciences 启动二次发行后，股价周三下跌14.5%，至35.47美元，超过周二的涨幅。** HRMY股价有望创下自2023年10月13日以来的最大单日跌幅，当时股价大跌30%。** 专注于罕见神经系统疾病的公司周二晚些时候宣布发行 800 万股股票，Marshman 基金信托公司和 Valor Equity Partners 公司各出售 400 万股股票 ** 根据美国证券交易委员会的招股说明书文件，Marshman 的持股将减至约 670 万股，或 11.7% 的股份，而总部位于芝加哥的 PE 公司 Valor 的 持股将减至约 720 万股，或 12.7% 的股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","LU0211326755.USD","LU0323591593.USD","LU0203345920.USD","LU0683600562.USD","BK4585","IE00BLSP4452.SGD","LU0320765489.SGD","LU0496365809.HKD","IE00BHPRN162.USD","LU0267386448.USD","IE0034235188.USD","LU1119994496.HKD","IE00B1XK9C88.USD","LU1064131342.USD","LU1162221912.USD","HRMY","BK4550","IE00B1BXHZ80.USD","BK4581","LU0787776722.HKD","IE00BKVL7J92.USD","IE00BKDWB100.SGD","LU1032466523.USD","BK4566","LU0320765646.SGD","LU0211331839.USD","LU","BK4207","LU0106831901.USD","LU0417517546.SGD","LU0215105999.USD","LU0234572021.USD","IE00BWXC8680.SGD","LU0211326839.USD","IE00BLSP4239.USD","LU0211327993.USD","IE00B3S45H60.SGD","BK4533","IE00BBT3K403.USD","LU0208291251.USD","BK4534","BK4588","LU0070302665.USD","IE00BYXW3230.USD","IE00BZ1G4Q59.USD","LU0238689110.USD","BK4504","IE000M9KFDE8.USD","LU0170899867.USD"],"gpt_icon":0},{"id":"2479783734","title":"Harmony Biosciences Holdings, Inc.股价重挫11.54% 市值跌2.42亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479783734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479783734?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:32","pubTimestamp":1730295143,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时32分，Harmony Biosciences Holdings, Inc.股票出现波动，股价急速下挫11.54%。Harmony Biosciences Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Harmony Biosciences Holdings, Inc.公司简介：Harmony Biosciences Holdings Inc是一家商业阶段的制药公司，致力于为患有罕见的神经系统疾病且未满足医疗需求的患者开发和商业化创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021322395bd8e21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021322395bd8e21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HRMY","BK4007"],"gpt_icon":0},{"id":"1158933773","title":"异动解读 | 和谐生物科学公司第三季度财报超预期 股价大涨16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1158933773","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158933773?lang=zh_cn&edition=full","pubTime":"2024-10-30 04:18","pubTimestamp":1730233099,"startTime":"0","endTime":"0","summary":"制药公司和谐生物科学公司股价今日盘中大涨16.14%,主要受公司刚公布的超预期第三季度财报数据所推动。根据公司27日晚间发布的最新季报,第三季度和谐生物实现营收1.86亿美元,超过分析师平均预期的1.84亿美元。截至上一交易日,和谐生物股价已累积上涨10.7%。市场预期公司业绩表现良好进一步推升当日大涨。分析师认为,和谐生物科学的优异财报反映了公司产品竞争力及未来发展潜力,给予\"买入\"等积极评级,成为推动股价上涨的主因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HRMY"],"gpt_icon":0},{"id":"2479457285","title":"和谐生物科学控股公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2479457285","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479457285?lang=zh_cn&edition=full","pubTime":"2024-10-29 22:03","pubTimestamp":1730210613,"startTime":"0","endTime":"0","summary":" * Harmony Biosciences Holdings Inc 公布的截至9月30日的季度调整后每股收益为79美分，高于去年同期的每股收益75美分。八位分析师对该季度的平均预期为每股收益 67 美分。华尔街预期为每股收益 45 美分至 75 美分。* 营收同比增长 16.1%，达到 1.8604 亿美元；分析师预期为 1.8406 亿美元。* Harmony Biosciences Holdings Inc公布的本季度每股收益为79美分。* 公司报告的季度净收入为 4609 万美元。* Harmony Biosciences Holdings Inc的股价本季度下跌了10.6%，今年迄今为止上涨了10.7%。华尔街对 Harmony Biosciences Holdings Inc 的 12 个月目标价中位数为 47.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY"],"gpt_icon":0},{"id":"1180315677","title":"异动解读 | 和谐生物第三季度超预期财报 盘中股价大涨6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1180315677","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180315677?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:52","pubTimestamp":1730209944,"startTime":"0","endTime":"0","summary":"和谐生物科学公司(Harmony Biosciences Holdings, Inc.)当日股价盘中大涨超过6%,主要受公司刚刚公布的靓丽第三季度财报提振。\n\n根据和谐生物27日晚间公布的财报数据,该公司在2024年第三季度实现营收1.86亿美元,超越分析师预期的1.84亿美元。公司每股收益为79美分,相比去年同期的63美分有所增长。\n\n得益于业绩向好,市场对和谐生物的前景评级趋于乐观,投资者对其未来增长潜力也愈发看重。截至上一交易日,和谐生物的股价已录得10.7%的累计涨幅。投资人对公司良好财报表现的预期,成为推动当日股价大涨的主要动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HRMY"],"gpt_icon":0},{"id":"1152437060","title":"异动解读 | 和谐生物第三季度财报向好 股价盘前大涨6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152437060","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152437060?lang=zh_cn&edition=full","pubTime":"2024-10-29 20:08","pubTimestamp":1730203696,"startTime":"0","endTime":"0","summary":"2024年10月29日,和谐生物科学公司(Harmony Biosciences Holdings, Inc., HRMY)股价在盘前交易中大涨6.01%,截至开盘前报37.33美元。\n\n和谐生物27日晚间公布的第三季度财报数据显示,该公司当季营收达1.86亿美元,超过分析师预期的1.84亿美元。每股收益为79美分,较去年同期的63美分有所增长。\n\n市场对这一靓丽的财报表现反应热烈,投资者对和谐生物的业绩表现预期向好,从而推高公司股价上涨。截至上一交易日,HRMY股价已录得10.7%的累计涨幅。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 和谐生物第三季度财报向好 股价盘前大涨6%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HRMY"],"gpt_icon":0},{"id":"2479618405","title":"BUZZ-第三季度收入超过预期，和谐公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2479618405","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479618405?lang=zh_cn&edition=full","pubTime":"2024-10-29 19:57","pubTimestamp":1730203045,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) 10月29日 - ** 和谐生物 股价盘前上涨4.4%至37.33美元** 制药公司第三季度营收1.86亿美元，高于分析师预计的1.84亿美元--LSEG** HRMY 第三季度每股收益为 79 美分，去年同期为 63 美分。** 截至上日收盘，股价累计上涨 10.7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY"],"gpt_icon":0},{"id":"2472270045","title":"Harmony Biosciences Holdings, Inc.盘中异动 早盘急速下挫5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472270045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472270045?lang=zh_cn&edition=full","pubTime":"2024-10-02 22:54","pubTimestamp":1727880894,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日22时54分，Harmony Biosciences Holdings, Inc.股票出现异动，股价快速下跌5.22%。Harmony Biosciences Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.09%。Harmony Biosciences Holdings, Inc.公司简介：Harmony Biosciences Holdings Inc是一家商业阶段的制药公司，致力于为患有罕见的神经系统疾病且未满足医疗需求的患者开发和商业化创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022254559719dfb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022254559719dfb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","HRMY"],"gpt_icon":0},{"id":"2470675110","title":"Harmony Biosciences Holdings, Inc.盘中异动 快速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470675110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470675110?lang=zh_cn&edition=full","pubTime":"2024-09-26 23:58","pubTimestamp":1727366318,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日23时58分，Harmony Biosciences Holdings, Inc.股票出现波动，股价快速拉升5.01%。Harmony Biosciences Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Harmony Biosciences Holdings, Inc.公司简介：Harmony Biosciences Holdings Inc是一家商业阶段的制药公司，致力于为患有罕见的神经系统疾病且未满足医疗需求的患者开发和商业化创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262358389719cddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262358389719cddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","HRMY"],"gpt_icon":0},{"id":"2459310220","title":"Harmony Biosciences Holdings, Inc.2024财年第二财季实现净利润11.59百万美元，同比减少66.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459310220","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459310220?lang=zh_cn&edition=full","pubTime":"2024-08-15 00:19","pubTimestamp":1723652348,"startTime":"0","endTime":"0","summary":"8月15日，Harmony Biosciences Holdings, Inc.公布财报，公告显示公司2024财年第二财季净利润为11.59百万美元，同比减少66.21%；其中营业收入为1.73亿美元，同比增加29.10%，每股基本收益为0.20美元。机构评级：截至2024年8月15日，当前有7家机构对Harmony Biosciences Holdings, Inc.目标价做出预测，其中目标均价为43.29美元，其中最低目标价为28.00美元，最高目标价为56.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408150019159598d2d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408150019159598d2d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HRMY"],"gpt_icon":0},{"id":"2459513479","title":"Harmony Biosciences Holdings, Inc.盘中异动 临近收盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459513479","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459513479?lang=zh_cn&edition=full","pubTime":"2024-08-14 03:59","pubTimestamp":1723579157,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日03时59分，Harmony Biosciences Holdings, Inc.股票出现波动，股价快速上涨5.00%。Harmony Biosciences Holdings, Inc.股票所在的生物技术行业中，整体涨幅为2.13%。Harmony Biosciences Holdings, Inc.公司简介：Harmony Biosciences Holdings Inc是一家商业阶段的制药公司，致力于为患有罕见的神经系统疾病且未满足医疗需求的患者开发和商业化创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814035917af97455c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814035917af97455c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","HRMY"],"gpt_icon":0},{"id":"2457799770","title":"BUZZ-Harmony Biosciences 第二季度业绩超预期后上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2457799770","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457799770?lang=zh_cn&edition=full","pubTime":"2024-08-07 01:21","pubTimestamp":1722964873,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) 8月6日 - ** 和谐生物 股价上涨4.7%，至32.37美元** 制药公司第二季度利润为1.728亿美元，高于华尔街预期的1.725亿美元 - LSEG** HRMY 第二季度利润为每小时 20 美分，高于预期的每小时亏损 6 美分。** 年初至今，股价上涨 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BUZZ","HRMY"],"gpt_icon":0},{"id":"1193979317","title":"异动解读 | 和谐生物科学控股公司季绩超预期 股价大涨7.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=1193979317","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193979317?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:43","pubTimestamp":1722951839,"startTime":"0","endTime":"0","summary":"和谐生物科学控股公司(Harmony Biosciences Holdings, Inc.)今日股价大涨7.69%,引发市场关注。公司此前公布的截至6月底的季度财报显示,当季业绩超出市场预期,这可能是导致股价大涨的主要原因。\n\n具体来看,和谐生物科学控股公司当季调整后每股收益为0.20美元,高于分析师平均预期的亏损0.06美元。营收同比增长28.8%至1.7281亿美元,也超过了分析师预期的1.7253亿美元。\n\n公司当季净收入为1153万美元。财报数据表现出色,反映了公司业务的良好发展态势,这增强了投资者对公司长期前景的信心,推动股价上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.harmonybiosciences.com","stockEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":-0.0468},{"period":"3month","weight":-0.0861},{"period":"6month","weight":0.1095},{"period":"1year","weight":0.166},{"period":"ytd","weight":0.0288}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Harmony Biosciences Holdings, Inc.于2017年7月25日成立，是一家商业阶段的制药公司，致力于为患有罕见的神经系统疾病且未满足医疗需求的患者开发和商业化创新疗法。该公司的产品WAKIX（pitolisant）是具有新颖作用机制或MOA的一流分子，专门设计用于通过与H3受体结合来增强大脑中的组胺信号传导。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.079082},{"month":2,"riseRate":0.5,"avgChangeRate":0.008817},{"month":3,"riseRate":0.5,"avgChangeRate":-0.015849},{"month":4,"riseRate":0,"avgChangeRate":-0.069867},{"month":5,"riseRate":0.5,"avgChangeRate":0.020636},{"month":6,"riseRate":0.75,"avgChangeRate":0.011425},{"month":7,"riseRate":0.75,"avgChangeRate":0.023571},{"month":8,"riseRate":0.75,"avgChangeRate":0.062136},{"month":9,"riseRate":0.6,"avgChangeRate":0.022496},{"month":10,"riseRate":0.6,"avgChangeRate":-0.014983},{"month":11,"riseRate":0.8,"avgChangeRate":0.070404},{"month":12,"riseRate":0.5,"avgChangeRate":0.030001}],"exchange":"NASDAQ","name":"Harmony Biosciences Holdings, Inc.","nameEN":"Harmony Biosciences Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Harmony Biosciences Holdings, Inc.(HRMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Harmony Biosciences Holdings, Inc.(HRMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Harmony Biosciences Holdings, Inc.,HRMY,Harmony Biosciences Holdings, Inc.股票,Harmony Biosciences Holdings, Inc.股票老虎,Harmony Biosciences Holdings, Inc.股票老虎国际,Harmony Biosciences Holdings, Inc.行情,Harmony Biosciences Holdings, Inc.股票行情,Harmony Biosciences Holdings, Inc.股价,Harmony Biosciences Holdings, Inc.股市,Harmony Biosciences Holdings, Inc.股票价格,Harmony Biosciences Holdings, Inc.股票交易,Harmony Biosciences Holdings, Inc.股票购买,Harmony Biosciences Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Harmony Biosciences Holdings, Inc.(HRMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Harmony Biosciences Holdings, Inc.(HRMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}